MedPhab 3.5 years of successfully accelerating innovation in photonics-based medical devices
Cork, Ireland was the location in where MedPhab partners gathered for their M42 meeting on June 14 and 15, 2023. The host Tyndall Institute made sure their guests were comfortable to discuss the progress of the pilot line in the last six months.
The Consortium, led by Prof. Jussi Hiltunen and supported by the management of ABIMI, is in a good position on the progress of the project’s objectives after successfully passing the review meeting with the European Commission and reviewers few months back. The use-cases, that validate technology maturity of MedPhab partners, are close to finish, however still challenges are ahead on the last steps of this process. The open call for the external demo cases finalized in April 2023, and 8 cases were selected in the last cut-off to start implementation in July 2023. For this reason, the Consortium will propose extending the project duration and formally requesting approval from the European Commission. Special attention was given in the discussions about the MedPhab non-profit association as the continuity and sustainable model for MedPhb project, led by Christina Liedert, the Executive Director. In addition, the efforts of the dissemination and marketing were acknowledged and encouraged to continue in the upcoming events, such as COMPAMED MEDICA in Düsseldorf in November this year.
Do not miss to follow this successful story on the medphab.eu and medphab.com websites and their social media channels!